- Independent mental health service
Cygnet Acer Clinic
Assessment report published 21 July 2026
Contents
Ratings
Our view of the service
We assessed Cygnet Acer Clinic on 26 May 2026.
We undertook the assessment in response to concerns received regarding the safety and quality of care provided within the service.
Cygnet Acer Clinic was registered with CQC in May 2016 to deliver the regulated activities: Assessment or medical treatment for persons detained under the Mental Health Act 1983 and Treatment of disease, disorder or injury. The service had a controlled drugs accountable officer and a Registered Manager.
We visited the following wards as part of the assessment:
Acer Upper – Acute Service for women of working age with 14 beds.
At this assessment, we identified breaches of Regulations 10 (Dignity and Respect), 12 (Safe Care and Treatment), and 17 (Good Governance
At this assessment we assessed 1 assessment service groups; Acute wards for adults of working age and psychiatric intensive care units where we assessed 33 quality statements.
We have assessed the service against ‘Right support, right care, right culture’ guidance to make judgements about whether the provider guaranteed people with a learning disability and autistic people respect, equality, dignity, choices, independence and good access to local communities that most people take for granted.
We rated the service as requires improvement. In the acute wards for adults of working age, we found 3 breaches of regulations in relation to dignity and respect, safe care and treatment, and good governance. Concerns included the management of risks associated with repeated self-harm, the quality and effectiveness of care planning and crisis planning, the cleanliness and maintenance of patient environments, patients' cultural and religious needs not being consistently recognised and/or respected, and the effectiveness of governance systems to identify, monitor and address risks and drive improvements in care.
We are taking regulatory action in response to the concerns identified during this assessment. Details of this action will be published once the regulatory process has concluded.